October 6, 2011
Cambridge, MA
Effective and cost-efficient legal guidance now, more than ever, is essential for the protection of innovator small molecule and biologic pharmaceutical products. During this program our panelists will discuss:
• An Overview of the Follow-On Biologics Framework
• Strategies for Successfully Litigating Hatch-Waxman and Biosimilar Cases
• Strategies for Maximizing Small Molecule and Biosimilar Patent Protection
Finnegan
55 Cambridge Parkway
Cambridge, MA 02142
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
WTR Live: Brand Strategy Summit Europe 2024
March 12-13, 2024
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.